How Much Does Zepbound Cost? Every Tirzepatide Price Channel Compared
Complete Zepbound and tirzepatide cost breakdown for 2026. Compare LillyDirect vial pricing, pharmacy list prices, savings card options, insurance coverage, and lower-cost GLP-1 alternatives.
Zepbound (tirzepatide) lists at approximately $1,086 per month at retail pharmacies, but almost nobody pays that number. With covered commercial insurance and the manufacturer savings card, monthly cost drops as low as $25. Without coverage, LillyDirect self-pay vials run $349-$699 per month depending on dose, cutting 35-70% off list price. Tirzepatide earned its demand with results: the SURMOUNT-1 trial published in the New England Journal of Medicine in 2022 recorded 20.9% average body weight loss at 72 weeks on the 15mg dose, and the head-to-head SURMOUNT-5 trial found tirzepatide outperformed semaglutide 20.2% to 13.7%. This guide maps every route to the medication, what each actually costs in 2026, and the lower-priced GLP-1 program alternatives when branded tirzepatide does not fit your budget.
Average Costs Comparison
Your Zepbound price depends almost entirely on which channel you use: insurance plus savings card, direct-from-manufacturer vials, retail cash, or a telehealth GLP-1 program built on lower-cost alternatives. Here is the 2026 comparison:
| Provider | Monthly Cost | Per Dose | Consultation | Shipping | Notes |
|---|---|---|---|---|---|
| Commercial Insurance + Savings Card | As low as $25/month | N/A | Standard visit copay | N/A (pharmacy pickup) | Requires plan coverage for Zepbound; Lilly savings card caps cost for covered commercial patients |
| LillyDirect Self Pay (vials) | $349-$699/month by dose | Four single-dose vials/month | Requires outside prescription | Free | 2.5mg $349, 5mg $499, higher doses $599-$699; official Lilly channel, no insurance needed |
| Retail Pharmacy (cash, pens) | $1,086-$1,300/month | Four pens/month | Requires outside prescription | N/A (pharmacy pickup) | Full list price; only makes sense as a stopgap or where other channels are unavailable |
| MEDVi (GLP-1 program) | From $179/month | N/A (subscription) | Included | Free | Semaglutide-based weight loss program; lower-cost GLP-1 alternative to branded tirzepatide |
| TrimRx (GLP-1 program) | From $179/month | N/A (subscription) | Included | Free | GLP-1 program with provider oversight; converted a $300 coupon-page visitor in our own tracking data |
| Maximus (GLP-1 program) | From $99.99/month | N/A (subscription) | Included | Free | Entry GLP-1 pricing among telehealth programs in our comparison set |
Detailed Price Breakdown by Channel
LillyDirect Self Pay Vials
LillyDirect is the manufacturer channel selling Zepbound single-dose vials directly to self-pay patients with a valid prescription. The 2.5mg starting dose costs $349 per month and the 5mg maintenance dose $499, with higher doses in the $599-$699 range. Vials require drawing with a syringe rather than using an autoinjector pen, which is the tradeoff for the discount.
Insurance + Lilly Savings Card
If your commercial plan covers Zepbound, the Lilly savings card reduces your copay to as low as $25 per month. If your plan does not cover it, the card still discounts the retail price, bringing typical cost to roughly $550-$650 per month. Coverage requires prior authorization at most plans, documented BMI criteria, and sometimes step therapy through older medications first.
Telehealth GLP-1 Programs
When branded tirzepatide exceeds your budget, telehealth weight loss programs built on semaglutide deliver GLP-1 treatment at $99-$227 per month with prescriber oversight, at the cost of somewhat lower average weight loss (13.7% vs 20.2% in the SURMOUNT-5 head-to-head). Maximus starts at $99.99 per month, MEDVi and TrimRx at $179 per month, with consultation and shipping included.
Insurance Coverage for Zepbound
Coverage for weight loss GLP-1 medications improved but remains inconsistent. According to Kaiser Family Foundation employer survey data, 38% of large employer health plans covered GLP-1 medications for weight loss in 2025, up from 24% in 2023. The December 2024 FDA approval of Zepbound for obstructive sleep apnea opened a second coverage pathway, because sleep apnea is not subject to the weight loss exclusions many plans and Medicare apply.
Commercial Insurance
Coverage: 38% of large employer plans (2025), prior authorization standard
Plans that cover Zepbound typically require BMI of 30 or higher (or 27 with comorbidity), prior authorization, and sometimes documented lifestyle program participation. With coverage, the savings card brings cost to $25/month.
Medicare
Coverage: Excluded for weight loss; possible for sleep apnea indication
Medicare Part D excludes medications prescribed for weight loss. Zepbound prescribed for diagnosed obstructive sleep apnea under its December 2024 FDA indication may be covered; formulary placement varies by plan.
Medicaid
Coverage: Varies by state, generally limited
A minority of state Medicaid programs cover GLP-1 medications for obesity, each with prior authorization gates. Check your state formulary directly.
Self-Pay
Coverage: N/A
LillyDirect vials ($349-$699/month) are the cheapest branded route without insurance. Telehealth semaglutide programs ($99-$227/month) are the value alternative if branded tirzepatide is out of reach.
Zepbound vs Mounjaro vs Alternatives
There is no generic tirzepatide; patent protection extends into the 2030s. Zepbound and Mounjaro contain the identical molecule at identical doses; only the FDA label differs (chronic weight management and sleep apnea for Zepbound, type 2 diabetes for Mounjaro). Your real cost comparison is between channels and between GLP-1 molecules.
| Medication | Compounded/Generic | Brand-Name | Savings |
|---|---|---|---|
| Zepbound pens (retail cash) | No generic exists | $1,086-$1,300/month | Baseline (most expensive route) |
| Zepbound vials (LillyDirect) | No generic exists | $349-$699/month | 35-70% vs retail pens |
| Mounjaro (with T2D diagnosis + coverage) | No generic exists | Often $25-$100/month copay | Insurance route for diabetics |
| Semaglutide-based telehealth programs | Program pricing | $99-$227/month | 70-90% vs Zepbound retail; lower expected weight loss |
How to Save on Zepbound and Tirzepatide
- Check your insurance first, every year: GLP-1 coverage is being added and dropped plan by plan, and coverage plus the savings card ($25/month) beats every other channel.
- Use LillyDirect vials if you are self-pay: $349-$499 for starting and maintenance doses is the lowest branded price, and refill timing discounts can reduce higher-dose costs.
- Ask about the sleep apnea pathway if you have diagnosed OSA: the December 2024 indication opens coverage, including potential Medicare Part D, that the weight loss label does not.
- Stay on the lowest effective dose: vial pricing scales with dose, so a $349 (2.5mg) or $499 (5mg) protocol costs hundreds less per year than automatic escalation to maximum dose.
- Price the semaglutide alternative honestly: at $99-$227/month, telehealth GLP-1 programs cost 70-90% less; SURMOUNT-5 showed tirzepatide ahead 20.2% to 13.7%, so you are trading some efficacy for substantial savings.
- Pay with HSA/FSA funds: prescription GLP-1 medications and program fees are qualified medical expenses.
Hidden Costs to Watch For
- Dose escalation pricing: LillyDirect vial prices climb with dose ($349 to $699), so the advertised starting price understates steady-state cost for many users.
- Prescription and consult fees: LillyDirect requires a prescription; if you lack a prescriber, add a telehealth visit fee ($39-$129) to get one.
- Refill timing rules: some LillyDirect discounts depend on refilling within a set window; missing it resets you to higher pricing.
- Savings card expiration and caps: manufacturer cards carry annual maximums and program end dates; the $25 price assumes active coverage and card enrollment.
- Syringes and sharps supplies for vial users, typically $10-$20/month if not included.
- Appetite-adjacent costs cut both ways: grocery spending typically falls, but plan for protein-focused nutrition and, ideally, resistance training to protect lean mass during rapid loss.
Frequently Asked Questions
How much does Zepbound cost per month without insurance?
Without insurance, your cheapest branded route is LillyDirect self-pay vials: $349 per month for the 2.5mg starting dose, $499 for the 5mg maintenance dose, and $599-$699 for higher doses, shipped free with a valid prescription. Retail pharmacy cash price for Zepbound pens runs $1,086-$1,300 per month, which only makes sense as a short-term stopgap. The Lilly savings card also discounts non-covered patients to roughly $550-$650 per month at retail. If those numbers do not fit your budget, telehealth GLP-1 programs built on semaglutide start at $99.99 per month at Maximus and $179 at MEDVi and TrimRx, consultation included. The efficacy tradeoff is real but bounded: the SURMOUNT-5 head-to-head trial measured 20.2% average weight loss for tirzepatide versus 13.7% for semaglutide at 72 weeks.
Is Zepbound covered by insurance?
Coverage is improving but far from universal. Kaiser Family Foundation employer survey data put GLP-1 weight loss coverage at 38% of large employer plans in 2025, up from 24% in 2023. Where covered, expect prior authorization requiring BMI of 30 or higher (or 27 with a weight-related condition), and sometimes step therapy or documented lifestyle program participation. With active coverage, the Lilly savings card caps your cost as low as $25 per month. Medicare Part D excludes weight loss medications entirely, but Zepbound gained FDA approval for obstructive sleep apnea in December 2024, and prescriptions written for diagnosed OSA fall outside the weight loss exclusion, creating a legitimate Medicare pathway for qualifying patients. Medicaid coverage exists in only a minority of states. Call the number on your insurance card and ask specifically about Zepbound with your diagnosis before assuming either answer.
What is the difference between Zepbound and Mounjaro?
Nothing chemically. Zepbound and Mounjaro are the same molecule, tirzepatide, made by the same manufacturer at the same doses. The difference is the FDA label: Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management and, since December 2024, obstructive sleep apnea. The label difference drives the price difference. If you have type 2 diabetes, insurance routinely covers Mounjaro, often landing your copay at $25-$100 per month. If you are prescribed tirzepatide for weight alone, you are in Zepbound territory where coverage is the exception and self-pay channels matter. This is also why prescribing Mounjaro off-label for weight to capture diabetes coverage does not work: plans verify the diagnosis during prior authorization. Choose the product that matches your actual diagnosis and then optimize the channel, because the medication in the pen or vial is identical.
How much weight can I expect to lose on tirzepatide for the cost?
The SURMOUNT-1 trial published in the New England Journal of Medicine in 2022 recorded 20.9% average body weight loss at 72 weeks on the 15mg dose, with 91% of participants losing at least 5% of body weight. For a 250-pound starting weight, the average outcome translates to roughly 52 pounds. In cost terms at LillyDirect pricing, a 72-week course averaging $500 per month runs about $9,000, or roughly $170 per pound lost at the average response. The comparison point: semaglutide delivered 13.7% in the SURMOUNT-5 head-to-head, so a $179 per month semaglutide program costing $3,200 over the same period yields around $95 per pound at average response. Individual results spread widely around averages, and weight regain after discontinuation is well documented, so the honest budgeting assumption is ongoing maintenance cost, not a one-time course.
Why are Zepbound vials cheaper than pens?
Lilly prices LillyDirect vials at $349-$699 per month against $1,086-$1,300 retail for pens, a 35-70% discount, for two business reasons. First, vials skip the autoinjector device cost and the retail pharmacy distribution chain, shipping directly from the manufacturer to your door. Second, LillyDirect was built to compete with compounded tirzepatide alternatives on price while keeping patients on FDA-approved product from the original manufacturer. The practical difference for you is administration: vials require drawing your dose with a syringe rather than clicking a pen, which takes a few minutes of technique learning but is the same subcutaneous injection. The medication inside is identical FDA-approved tirzepatide. For self-pay patients comfortable with a syringe, vials are the clear value; the pen premium buys convenience, not better medicine.
Are cheaper tirzepatide alternatives legitimate?
Depends which alternative. After the FDA declared the tirzepatide shortage resolved in December 2024, mass-produced compounded tirzepatide lost its legal basis, and pharmacies faced enforcement deadlines in early 2025. Websites still selling cheap "tirzepatide" today deserve skepticism about sourcing, dosing accuracy, and legality. The legitimate budget alternatives are different: telehealth programs built on semaglutide, prescribed by licensed providers, at $99-$227 per month, such as Maximus from $99.99, MEDVi and TrimRx from $179. Semaglutide remains a proven GLP-1 with 13.7-14.9% average weight loss in trials (SURMOUNT-5 and STEP 1), just below tirzepatide performance. LillyDirect vials at $349-$499 are the legitimate way to stay on branded tirzepatide affordably. The rule that protects you: a licensed US prescriber, a licensed US pharmacy, and a medication name that matches the prescription.
How much does a year of Zepbound cost?
Channel determines the annual number more than anything else. Covered commercial insurance with the savings card: roughly $300 per year at the $25 monthly cap, plus visit copays. LillyDirect self-pay vials: $4,200-$6,700 depending on your maintenance dose, since the 2.5mg starting tier at $349 gives way to $499-$699 tiers as you titrate. Retail pharmacy cash: $13,000-$15,600, which nobody should pay for a full year given the alternatives. Telehealth semaglutide programs as the budget alternative: $1,200-$2,700 per year at $99-$227 monthly. Two budgeting realities: dose escalation is standard protocol, so model your year on a maintenance dose rather than the starting tier, and weight regain after stopping is well documented in trial extension data, which means the honest planning horizon is multi-year maintenance, not a single 12-month course.
Does Zepbound cost more at higher doses?
Through LillyDirect vials, yes, substantially: the 2.5mg starting dose runs $349 per month, 5mg runs $499, and the 7.5mg and 10mg tiers run $599-$699. Standard titration moves most users off the starting dose within 4-8 weeks, so the $349 figure in advertising materially understates typical steady-state cost. Retail pens carry roughly the same list price across doses, and insurance copays with the savings card do not scale with dose at all, which flips the math: self-pay users have a real financial incentive to find their lowest effective maintenance dose, while covered users do not. Clinically, the SURMOUNT-1 dose groups showed meaningful weight loss at every tier, 15% average at 5mg versus 20.9% at 15mg, so staying at a middle dose that your results and side effects support is a legitimate strategy that can save a self-pay user $1,200-$2,400 per year.
How can I get insurance to cover Zepbound?
Work the sequence: first call the member number on your card and ask whether Zepbound is on formulary, what tier, and what the prior authorization requires. Typical criteria: BMI of 30 or higher, or 27 with a documented weight-related condition like hypertension or type 2 diabetes, sometimes plus documented participation in a lifestyle program. Second, have your prescriber submit the prior authorization with complete documentation the first time; incomplete submissions cause most denials. Third, if you have diagnosed obstructive sleep apnea, ask your prescriber about Zepbound under its December 2024 OSA indication, which bypasses the weight loss exclusions many plans and Medicare apply. Fourth, appeal denials: plans overturn a meaningful share on first appeal when the clinical criteria are actually met. Fifth, check every open enrollment whether your employer added GLP-1 coverage, because adoption moved from 24% to 38% of large employer plans between 2023 and 2025 and continues shifting year to year.
Is Mounjaro cheaper than Zepbound?
Only if you have type 2 diabetes, and then dramatically so. Mounjaro and Zepbound are the identical tirzepatide molecule, but insurance treats the labels differently: diabetes medications enjoy broad formulary coverage, so a T2D diagnosis typically lands Mounjaro at a $25-$100 monthly copay, while weight-prescribed Zepbound faces exclusions and prior authorization walls. Without a diabetes diagnosis, the path inverts. You cannot legitimately access diabetes-label coverage, plans verify the diagnosis during authorization, and cash prices for the two products are comparable at retail, so Zepbound through LillyDirect vials at $349-$699 becomes the cheaper legitimate route. If you have prediabetes, an honest conversation with your prescriber about your actual diagnosis matters, because prediabetes alone does not qualify for Mounjaro coverage under most plans. Match the product to your real diagnosis, then optimize the channel within that lane; label-shopping without the diagnosis fails at prior authorization and wastes weeks.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- FDA Drug InformationGLP-1 medication approvals and safety
- NIH National Institute of DiabetesWeight management research
- CDC Obesity InformationObesity statistics and health impacts
- Obesity Medicine AssociationClinical obesity treatment guidelines
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
Ready to Compare Providers?
Use our cost calculator to get personalized pricing estimates based on your insurance and location.
Disclaimer: Pricing information is based on publicly available data and may change without notice. Actual costs depend on your specific treatment plan, insurance coverage, and provider. Always verify current pricing with providers before purchasing. This article is for informational purposes only and is not financial or medical advice. We may receive compensation through affiliate links, which helps support our research.